The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program “bridges biosciences, clinical therapeutics, population health, epidemiology, biostatistics, and health services and policy research to better understand choosing, using and losing medications within the context of medication safety and effectiveness.” For more information, please visit their website: http://www.safeandeffectiverx.com/. DSECT/DSEN present monthly online seminars for faculty, staff, trainees, decision makers and other stakeholders engaged in the field of drug safety and effectiveness.
This month’s webinar will take place:
Date: Thursday, September 24, 2020
Time: 3:00 pm EST – 4:00 pm EST
Title: “The opioid epidemic in Canada – using administrative databases from 2000 and 2017”
Presented by: Dr. Wasem Alsabbagh, Assistant Professor, School of Pharmacy, University of Waterloo.
To RSVP click the following link: https://attendee.gotowebinar.com/register/5041022623914818315
For more details, please see the event page: http://www.safeandeffectiverx.com/events/
Dr. Anick Berard will present The Canadian Mother-Child Cohort Initiative as part of the DSECT/DSEN Monthly Seminar Series on Thursday, May 23, 2019 between 3:00 pm and 4:00 pm EST.
Click to register.
Abstracts accepted for poster and oral presentation at the 2018 American College of Rheumatology (ACR) Annual Meeting are now available online: http://acrabstracts.org/. If you are a CANRAD member and would like your abstract listed on our website, please contact Autumn Neville: [email protected]
The focus of this month’s newsletter is on software tools for evaluating data quality and modifying or correcting data to address deficiencies in quality. Researchers and analysts often seek to implement program code that can be used to…
Email Newsletter: November 2013
Sent by: Lisa Lix
Department of Community Health Sciences, University of Manitoba
The focus of this month’s newsletter is on software tools for evaluating data quality and modifying or correcting data to address deficiencies in quality. Researchers and analysts often seek to implement program code that can be used to routinely and systematically produce measures of data completeness, correctness, and timeliness. Access to data quality macros or subroutines means that reports can be consistently generated with just a few keystrokes. Routine data quality evaluations are important for ensuring that data quality does not erode over time, and they can be the basis for ongoing dialogues between data providers and data users. Specialized software tools to measure and address specific data quality issues, such as missing data, are equally important to include in the analysts’ toolkit.
At the 2013 SAS®Global Forum in San Francisco, there were a number of presentations on software tools for data quality, two of which were made by analysts working with Canada’s administrative health data. I have provided links to these technical papers in the Links of Interest. As well, I recently came across an interesting website that highlights a recent SAS® book entitled “Data Quality for Analytics” that you may find useful.
Data Quality for Analytics: http://www.sascommunity.org/wiki/Gerhard%27s_Blog
Links of Interest
Data Fitness: A SAS® Macro-based Application for Data Quality of Large Health Administrative Data: http://support.sas.com/resources/papers/proceedings13/075-2013.pdf
A Flexible Method to Apply Multiple Imputation Using SAS/IML® Studio: http://support.sas.com/resources/papers/proceedings13/283-2013.pdf
In-Database Data Quality – Performance for Big Data: http://support.sas.com/resources/papers/proceedings13/079-2013.pdf
Networking and Training
Delivering High Quality Hospital Data: Towards Clinically Meaningful Information
e-Health 2014 Conference
The PHAC’s arthritis website which includes links to arthritis related reports and publications.
The Chronic Disease Surveillance Division at the Public Health Agency of Canada has recently launched the following data cube on its public website: Arthritis in Canada Update
Using a nationally representative sample of 25,978 Canadians aged 15 years and older from the 2010-11 Canadian Community Health Survey, this data cube provides the latest statistics on the impact of arthritis on Canadians.
Video with Dr. Diane Lacaille, Rheumatologist at the University of British Columbia and Research Scientist at the Arthritis Research Centre of Canada
Biologics use by rheumatoid arthritis patients was associated with a 25% reduction in the risk of premature death, compared to patients without exposure to biologics, based on data from a population-based study of more than 4,000 patients. Dr. Diane Lacaille of the Arthritis Research Center of Canada discusses the results at the American College of Rheumatology’s annual meeting.